TABLE 2.
Cytochrome P450 enzymes | ||
---|---|---|
Essential: CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A | ||
Experimental System | Inhibition | Induction |
Recombinant enzymes | As needed | NA |
Human liver microsomes | a | NA |
Human hepatocytes | As needed | a |
Human intestinal microsomes | As needed | NA |
Human intestinal cells | As needed | As neededb |
Human kidney microsomes | As needed | NA |
Human kidney cells | As needed | As neededb |
Other cell lines | As needed | NA |
UGTs | ||
---|---|---|
Essential: UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A8, UGT1A9, UGT1A10, UGT2B7, UGT2B10, UGT2B15 | ||
Experimental System | Inhibition | Induction |
Recombinant enzymes | As needed | NA |
Human liver microsomes | a | NA |
Human hepatocytes | a | a |
Human intestinal microsomes | As needed | NA |
Human intestinal cells | As needed | As neededb |
Human kidney microsomes | As needed | NA |
Human kidney cells | As needed | As neededb |
Other cell lines | As needed | NA |
Other Enzymes that May Be Considered | ||
---|---|---|
hCE1, hCE2, SULT1A1, SULT1A3, SULT1B1, SULT1E1, SULT2A1 | ||
Experimental System | Inhibition | Induction |
Recombinant enzymes | a | NA |
Human liver microsomes | a | NA |
Human hepatocytes | As needed | a |
Human intestinal microsomes | As needed | NA |
Human intestinal cells | As neededb | As neededb |
Human kidney microsomes | As neededb | NA |
Human kidney cells | As neededb | As neededb |
Transporters | ||
---|---|---|
Essential: BCRP, BSEP, MATE1, MATE2-K, MRP2, MRP3, NTCP, OATP1B1, OATP1B3, OATP2B1, OAT, OCT, P-gp | ||
Experimental System | Inhibition | Induction |
Transfected cell lines (single, double) | a | NA |
Human intestinal cells | As neededb | As neededb |
Human kidney cells | As neededb | As neededb |
Human hepatocytes | a | a |
Membrane vesicles | a | NA |
BCRP, breast cancer resistance protein; BSEP, bile salt export pump; hCE, human carboxylesterase; MATE, multidrug and toxin extrusion protein; MRP, multidrug resistance–associated protein; NA, not applicable; NTCP, sodium taurocholate–cotransporting polypeptide; OAT, organic anion transporter; OATP, organic anion–transporting polypeptide; OCT, organic cation transporter; P-gp, P-glycoprotein; SULT, sulfotransferase.
Essential system. Inhibition studies in hepatocytes may involve multiple transporters.
These models represent an emerging field and will be refined with time. Expression levels of enzymes and transporters in these models are lower than those in vivo (Speer et al., 2019; Chapron et al., 2020; Kasendra et al., 2020).